AN ENGINEERED PROBIOTIC PRODUCES A TYPE III INTERFERON IFNL1 AND REDUCES INFLAMMATIONS IN… Application WO-2023224554-A1 World Intellectual Property Organisation (WIPO) 23 Nov 2023